Tharimmune, Inc.
Why Robinhood?
You can watch THAR and buy or sell other stocks, ETFs, and their options commission-free!About THAR
Canton Strategic Holdings, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure.
THAR Key Statistics
Stock Snapshot
The current Tharimmune, Inc.(THAR) stock price is $4.74, with a market capitalization of 175.91M. The stock trades at a price-to-earnings (P/E) ratio of -1.18.
Tharimmune, Inc.(THAR) stock opened on 2026-05-13 at —. The price climbed to — and dipped to —.
Tharimmune, Inc.(THAR) shares are trading with a volume of 0, against a daily average of 482.01K.
In the last year, Tharimmune, Inc.(THAR) shares hit a 52-week high of $9.08 and a 52-week low of $1.08.
In the last year, Tharimmune, Inc.(THAR) shares hit a 52-week high of $9.08 and a 52-week low of $1.08.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.